Moreover, the significantly high frequency of DIH cases observed in our analyses highlights the importance of developing a NAT2 genotyping test for clinical routine use in a personalised way, which would certainly bring significant benefits to TB treatment outcomes in this population. Here, NAT2 is linked to tuberculosis.